Angioplasty

Isquemia crítica de miembros inferiores: las re-hospitalizaciones frecuentes muestran la magnitud del problema

BEST-CLI: Revascularization of Critical Lower Limb Ischemia, a Pragmatic Study

Critical lower limb ischemia (CLLI) is associated with a major deterioration in quality of life and a significant increase in morbidity and mortality. Its estimated annual incidence is 220 to 3500 cases per million people, with an expected prevalence of 11% of patients with peripheral arterial disease. CLLI is the “terminal” stage of peripheral artery<a href="https://solaci.org/en/2022/11/22/best-cli-revascularization-of-critical-lower-limb-ischemia-a-pragmatic-study/" title="Read more" >...</a>

See the Presentations of the 12th ProEducar Fellows Course

During SOLACI-SOCIME 2022, our traditional education program for young interventionists ProEducar Fellows Course was held.&nbsp; Discover the presentations of the prestigious interventionists that made part of this 12th edition here below.&nbsp; Dr. Leandro Lasave (ARG) –&nbsp;“Transradial access: When and how? Practical lesson for access without complications” PRESENTATION Dr. Alejandro Alcocer (MEX) –&nbsp;“Practical demonstration of aortic<a href="https://solaci.org/en/2022/11/21/see-the-presentations-of-the-12th-proeducar-fellows-course/" title="Read more" >...</a>

Disección coronaria espontánea: ¿Hay diferencias entre hombres y mujeres?

Spontaneous Coronary Artery Dissection: Are There Differences Between Men and Women?

Spontaneous coronary artery dissection is one of the causes of acute coronary syndrome, with a prevalence between 1 and 4%, that might reach up to 35% in women &lt;50&nbsp;years old, according to recent studies. As dissections are more frequent in women, research focuses on this population. Small retrospective studies have shown different triggers and predisposing<a href="https://solaci.org/en/2022/10/28/spontaneous-coronary-artery-dissection-are-there-differences-between-men-and-women/" title="Read more" >...</a>

Disección coronaria espontánea: ¿cuál es su tratamiento y pronóstico?

Spontaneous Coronary Artery Dissection: Treatment and Prognosis

Spontaneous coronary artery dissection (SCAD) is a non-traumatic nor iatrogenic event that causes a separation of the coronary artery tissue due to an intimal tear or a mural spontaneous hemorrhage. This event is most frequent in young females and usually causes an acute myocardial infarction that could be major. It accounts for 1% to 4%<a href="https://solaci.org/en/2022/10/21/spontaneous-coronary-artery-dissection-treatment-and-prognosis/" title="Read more" >...</a>

TRICVALVE en pacientes con Insuficiencia tricuspídea severa: resultados alentadores a 6 meses

Patients with INOCA in the ISCHEMIA Trial

There has been an increase in the diagnosis of patients with proven ischemia who did not present obstructive coronary lesions (defined as the absence of stenosis ≥50%), called ischemia with non-obstructive coronary arteries (INOCA). These patients are at a higher risk for major adverse cardiac events (MACE) compared with the rest of the population. The<a href="https://solaci.org/en/2022/10/18/patients-with-inoca-in-the-ischemia-trial/" title="Read more" >...</a>

Resultados del estudio COMPARE a 2 años: Balones cubiertos de Paclitaxel con bajas dosis vs altas dosis

Results of the COMPARE Study After 2 Years: Low Dose vs. High Dose Paclitaxel-Coated Balloons

The development of new devices and techniques has expanded the range of patients who benefit from endovascular treatment of femoropopliteal lesions. Paclitaxel-eluting devices have improved clinical results and treated-vessel patency at follow-up compared with conventional angioplasty. Currently, devices with different doses of paclitaxel are available in the market. The COMPARE (Compare I Pilot Study for<a href="https://solaci.org/en/2022/10/14/results-of-the-compare-study-after-2-years-low-dose-vs-high-dose-paclitaxel-coated-balloons/" title="Read more" >...</a>

nefroproteccion

TEATE Trial: Urine Alkalinization as a Target to Prevent Contrast-Associated Kidney Injury

Acute kidney injury related to iodinated contrast significantly increases morbidity and mortality after angiography or angioplasty. According to registries, its prevalence can vary from 2% in low-risk population to up to 50% in high-risk subjects. Its risk factors include previous renal failure, diabetes, age, and the amount/type of contrast used. As a preventive measure, international<a href="https://solaci.org/en/2022/10/03/teate-trial-urine-alkalinization-as-a-target-to-prevent-contrast-associated-kidney-injury/" title="Read more" >...</a>

Endovascular Treatment of Femoropopliteal Segment &#8211; SOLACI-SOCIME 2022

&#x2714;&#xfe0f; Endovascular Treatment of Femoropopliteal Segment &#8211; SOLACI-SOCIME 2022. &#x2714;&#xfe0f; SOLACI-SOCIME 2022 Scientific Session &#x1f468;&#x200d;&#x1f3eb; Content: 00:09 &#8211; How Palabras de bienvenida &#8211; Dr. Luis Virgen (MEX) 01:04 &#8211; Drug eluting stent. Which stent? &#8211; Dr. Yigal Piña (MEX) 33:39 &#8211; Rotablation in superficial femoral angioplasty &#8211; Dr. Alejandro Goldsmit (ARG)

La clave para tratar strokes: saber cuando detenerse

Should We Treat Stroke Percutaneously in TAVR?

Since its inception, transcatheter aortic valve replacement (TAVR) has improved greatly. However, there still are five big challenges to be solved: paravalvular leak, conduction disturbances, debilitating stroke, impaired kidney function, and major vascular complications and bleeding. Most cases of stroke are periprocedural and ischemic. So far, they have not been well analyzed in terms of<a href="https://solaci.org/en/2022/09/14/should-we-treat-stroke-percutaneously-in-tavr/" title="Read more" >...</a>

Nueva y discrepante información sobre los vasos no culpables en el infarto

Heparin Pretreatment in STEACS Treatment: A New Old Ally?

The treatment of ST-segment elevation acute coronary syndromes (STEACS) is undoubtedly reperfusion therapy with primary percutaneous coronary intervention. Similarly, nobody doubts that the pretreatment with more stronger antiplatelet agents has a role in such a treatment. In certain sites, unfractionated heparin (UFH) pretreatment is also administered before the patient enters the cath lab; its aim<a href="https://solaci.org/en/2022/09/12/heparin-pretreatment-in-steacs-treatment-a-new-old-ally/" title="Read more" >...</a>

Top